named Shire as one of the top takeover targets in the health- care industry, in an interview. ���The big pharma companies have issues with generics and Shire is sitting there saying they have a target of 15 percent revenue growth. How can a pharma...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Shires Sore Thumb Growth May... 12:27 PM
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account